Here’s what you should know:
1. Sources related to Mr. Icahn didn’t disclose the reasoning behind or the size of his investment.
2. Mr. Icahn previously held a position in Allergan, which he sold in the first quarter of 2017.
3. The company has been losing value hand over fist since July 2017. To date, Allergan’s stock has dropped 37.68 percent. When news of Mr. Icahn’s investment broke, Allergan’s stock traded up 3.3 percent.
4. Bloomberg said Mr. Icahn and Allergan CEO Brent Saunders have a long established history.
More articles on supply chain:
7 things for ASC leaders to know for Thursday — June 7, 2018
How ASCs are changing as CMS adds procedures, mandates quality reporting
Pain physician faces insurance fraud, perjury after referring workers comp cases to ASC, lab he owned: 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
